XFOR X4 Pharmaceuticals, Inc: institutional ownership and insider trading
95 funds reported holding $464M of X4 Pharmaceuticals, Inc in their latest 13F filings; in Q2 2026 funds net bought $28.0M, with 33 new positions and 26 funds selling out; over the last 12 months insiders bought $11.9K and sold $463K on the open market; over its last four quarters it reported revenue of $8.80M and net income of −$90.1M.
XFOR revenue and earnings
- Quarter ended Jun 30, 2026: revenue $2.40M, net income −$16.2M, EPS -0.13
- Quarter ended Mar 31, 2026: revenue $2.50M, net income −$20.2M, EPS -0.16
- Quarter ended Dec 31, 2025: revenue $2.33M, net income −$23.9M, EPS 2.25
- Quarter ended Sep 30, 2025: revenue $1.57M, net income −$29.8M, EPS -0.69
Famous investors holding XFOR
- Two Sigma (Two Sigma Investments): $90.7K, 0.0% of the portfolio
- Renaissance Technologies (Renaissance Technologies): $84.5K, 0.0% of the portfolio
Largest institutional holders of XFOR
- MORGAN STANLEY (MS, MS-PA, MS-PE, MS-PF, MS-PI, MS-PK, MS-PL, MS-PO, MS-PP, MS-PQ) — $44.2M
- FMR LLC — $38.9M
- Bain Capital Life Sciences Investors, LLC — $37.2M
- PERCEPTIVE ADVISORS LLC — $37.0M
- Saturn V Capital Management LP — $32.6M
- Empery Asset Management, LP — $32.4M
- Deep Track Capital, LP — $27.5M
- BlackRock, Inc. (BLK) — $25.9M
- Kalehua Capital Management LLC — $17.4M
- VANGUARD CAPITAL MANAGEMENT LLC — $17.4M
Recent XFOR insider trades
- Oct 16, 2026: Craig Adam R bought 4,600 shares ($11.9K)
- Oct 1, 2026: Kirske David sold 11,767 shares ($33.7K)
- Aug 12, 2026: Craig Adam R sold 47,436 shares ($211K)
- Aug 12, 2026: Volpone John sold 24,576 shares ($109K)
5%+ owners
- Deep Track Capital, LP: 8.3% (Schedule 13G/A, filed Aug 14, 2026)
- Perceptive Advisors LLC: 8.1% (Schedule 13G/A, filed Aug 14, 2026)
- BlackRock, Inc.: 5.9% (Schedule 13G, filed Jul 30, 2026)
- Venrock Healthcare Capital Partners III, L.P.: 5.6% (Schedule 13G, filed Sep 21, 2026)
Who owns the most XFOR stock?
The largest institutional holders of X4 Pharmaceuticals, Inc in the latest 13F filings are MORGAN STANLEY (MS, MS-PA, MS-PE, MS-PF, MS-PI, MS-PK, MS-PL, MS-PO, MS-PP, MS-PQ) ($44.2M), FMR LLC ($38.9M), Bain Capital Life Sciences Investors, LLC ($37.2M).
Are insiders buying or selling XFOR?
Over the last 12 months insiders bought $11.9K and sold $463K of X4 Pharmaceuticals, Inc stock on the open market (SEC Form 4).
Which famous investors own XFOR?
Two Sigma, Renaissance Technologies.
What was XFOR's revenue last quarter?
X4 Pharmaceuticals, Inc reported revenue of $2.40M for the quarter ended June 30, 2026, with net income of −$16.2M.
Which ETFs hold XFOR?
2 ETFs and mutual funds hold it among their top 100 positions, including MFLLX, FBTAX.